REGISTERED NUMBER: SC312958 (Scotland)

Unaudited Financial Statements for the Year Ended 31 December 2025

for

PRO-HEALTH PHARMACY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

M S Aziz

Mrs I Aziz

REGISTERED OFFICE:

The Snclair Building

18-20 Eagle Street

Unit 1/1, 1st Floor

Glasgow

G4 9XA

REGISTERED NUMBER:

SC312958 (Scotland)

ACCOUNTANTS:

NKA Chartered Certified Accountants

The Sinclair Building

18-20 Eagle Street

Unit 1/1, 1st Floor

Glasgow

G4 9XA

FIXED ASSETS

Intangible assets

4

660,902

755,317

Tangible assets

5

438,774

409,206

Investments

6

48,729

108,536

1,148,405

1,273,059

CURRENT ASSETS

Stocks

105,736

91,890

Debtors

7

1,100,476

1,006,619

Cash at bank

232,378

370,655

1,438,590

1,469,164

CREDITORS

Amounts falling due within one year

8

380,481

371,452

NET CURRENT ASSETS

1,058,109

1,097,712

TOTAL ASSETS LESS CURRENT LIABILITIES

2,206,514

2,370,771

CREDITORS

Amounts falling due after more than one year

9

(386,346

)

(471,306

)

PROVISIONS FOR LIABILITIES

(109,693

)

(102,301

)

NET ASSETS

1,710,475

1,797,164

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

1,710,375

1,797,064

1,710,475

1,797,164

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2026 and were signed on its behalf by:

M S Aziz - Director

1.	STATUTORY INFORMATION

PRO-HEALTH PHARMACY LIMITED is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences have been fully amortised in the current year.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance and 20% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 19 (2024 - 19 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 January 2025

and 31 December 2025

1,544,147

AMORTISATION

At 1 January 2025

788,830

Charge for year

94,415

At 31 December 2025

883,245

NET BOOK VALUE

At 31 December 2025

660,902

At 31 December 2024

755,317

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 January 2025

746,547

Additions

128,042

At 31 December 2025

874,589

DEPRECIATION

At 1 January 2025

337,341

Charge for year

98,474

At 31 December 2025

435,815

NET BOOK VALUE

At 31 December 2025

438,774

At 31 December 2024

409,206

6.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 January 2025

108,536

Additions

5,193

Disposals

(65,000

)

At 31 December 2025

48,729

NET BOOK VALUE

At 31 December 2025

48,729

At 31 December 2024

108,536

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade debtors

226,743

165,649

Amounts owed by participating interests

29,265

9,000

Other debtors

844,468

831,970

1,100,476

1,006,619

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Bank loans and overdrafts

80,044

80,000

Trade creditors

220,796

246,609

Taxation and social security

77,965

40,526

Other creditors

1,676

4,317

380,481

371,452

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.12.25

31.12.24

£

£

Bank loans

386,346

471,306

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

66,346

151,306